UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis international, 2019-01, Vol.30 (1), p.3-44

2019

Volltextzugriff (PDF)

Osteoporosis and the Ageing Skeleton

Biochemistry and Cell Biology of Ageing: Part II Clinical Science, 2019, Vol.91, p.453-476

2019

Volltextzugriff (PDF)

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis

Frontiers in immunology, 2021-06, Vol.12, p.687551

2021

Volltextzugriff (PDF)

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10117), p.230-240

2018

Volltextzugriff (PDF)

Interaction between bone and immune cells: Implications for postmenopausal osteoporosis

Seminars in cell & developmental biology, 2022-03, Vol.123, p.14-21

2022

Volltextzugriff (PDF)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis

Aging (Albany, NY.), 2020-05, Vol.12 (9), p.8583-8604

2020

Volltextzugriff (PDF)

Pathophysiology of osteoporosis: new mechanistic insights

Endocrinology and metabolism clinics of North America, 2012-09, Vol.41 (3), p.475-486

2012

Volltextzugriff (PDF)

Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

Menopause (New York, N.Y.), 2021-09, Vol.28 (9), p.973-997

2021

Volltextzugriff (PDF)

Prevention and treatment of postmenopausal osteoporosis

The Journal of steroid biochemistry and molecular biology, 2014-07, Vol.142, p.155-170

2014

Volltextzugriff (PDF)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Osteoporosis international, 2020-01, Vol.31 (1), p.1-12

2020

Volltextzugriff (PDF)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis international, 2013-01, Vol.24 (1), p.23-57

2013

Volltextzugriff (PDF)

Use of bone turnover markers in postmenopausal osteoporosis

The lancet. Diabetes & endocrinology, 2017-11, Vol.5 (11), p.908-923

2017

Volltextzugriff (PDF)

American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

Endocrine practice, 2020-05, Vol.26 (Suppl 1), p.1-46

2020

Volltextzugriff (PDF)

MiR‐503 Regulates Osteoclastogenesis via Targeting RANK

Journal of bone and mineral research, 2014-02, Vol.29 (2), p.338-347

2014

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016

Endocrine practice, 2016-09, Vol.22 (Suppl 4), p.1-42

2016

Volltextzugriff (PDF)

A broader strategy for osteoporosis interventions

Nature reviews. Endocrinology, 2020-06, Vol.16 (6), p.333-339

Reid, Ian R

2020

Volltextzugriff (PDF)

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Cochrane database of systematic reviews, 2022-05, Vol.5 (7), p.CD004523

2022

Volltextzugriff (PDF)

Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2049-2063

2016

Volltextzugriff (PDF)

Hip fracture trends in the United States, 2002 to 2015

Osteoporosis international, 2018-03, Vol.29 (3), p.717-722

2018

Volltextzugriff (PDF)

Circulating miR-181c-5p and miR-497-5p Are Potential Biomarkers for Prognosis and Diagnosis of Osteoporosis

The journal of clinical endocrinology and metabolism, 2020-05, Vol.105 (5), p.1445-1460

2020

Volltextzugriff (PDF)

Exploration of the miR‐187‐3p/CNR2 pathway in modulating osteoblast differentiation and treating postmenopausal osteoporosis through mechanical stress

The FASEB journal, 2024-07, Vol.38 (13), p.e23776-n/a

2024

Volltextzugriff (PDF)

Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways

European journal of pharmacology, 2019-09, Vol.859, p.172550-172550, Article 172550

2019

Volltextzugriff (PDF)

Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity

Biomedicine & pharmacotherapy, 2020-12, Vol.132, p.110923-110923, Article 110923

2020

Volltextzugriff (PDF)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil

Clinical interventions in aging, 2015-01, Vol.10, p.583-591

2015

Volltextzugriff (PDF)

MicroRNA‐218‐5p relieves postmenopausal osteoporosis through promoting the osteoblast differentiation of bone marrow mesenchymal stem cells

Journal of cellular biochemistry, 2020-02, Vol.121 (2), p.1216-1226

2020

Volltextzugriff (PDF)

1 – 25 von 16.949

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14.316)
Mit Volltextzugriff
(12.184)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(14.965)
Deutsch
(432)
Französisch
(288)
Japanisch
(257)
Spanisch
(188)
Chinesisch
(176)
Italienisch
(85)
Polnisch
(75)
Dänisch
(73)
Russisch
(71)
Schwedisch
(55)
Tschechisch
(48)
Portugiesisch
(44)
Norwegisch
(43)
Croatian
(35)
Ungarisch
(35)
Türkisch
(30)
Niederländisch
(27)
Finnisch
(25)
Bulgarisch
(16)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(14.577)
Female
(14.254)
Science & Technology
(12.016)
Life Sciences & Biomedicine
(11.763)
Middle Aged
(8.482)
Osteoporosis
(8.310)
Aged
(7.773)
Bone Density
(5.297)
Osteoporosis, Postmenopausal - Drug Therapy
(4.901)
Endocrinology & Metabolism
(4.311)
Biological And Medical Sciences
(3.965)
Medical Sciences
(3.613)
Osteoporosis, Postmenopausal - Prevention & Control
(3.486)
Risk Factors
(3.295)
Postmenopausal Women
(2.651)
Aged, 80 And Over
(2.634)
Bone Mineral Density
(2.626)
Bone Density - Drug Effects
(2.502)
Osteoporosis, Postmenopausal - Complications
(2.463)
Fractures
(2.397)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(14.701)
Connected Ingenta
(8.599)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(6.951)
EZB Electronic Journals Library
(5.951)
Springer journals
(3.858)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.052)
Standalone journals
(2.986)
IngentaConnect Journals
(2.708)
Access via ScienceDirect (Elsevier)
(2.464)
Access via Wiley Online Library
(1.627)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.578)
Oxford Journals
(1.357)
Wiley Online Library Full Collection 2018
(1.246)
Taylor & Francis Journals Auto-Holdings Collection
(875)
Taylor & Francis Online
(697)
Taylor & Francis
(695)
Oxford Journals 2020 Medicine
(648)
Nexis Uni
(454)
SAGE Journals
(273)
BMJ journals single titles
(215)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis and the Ageing Skeleton

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Interaction between bone and immune cells: Implications for postmenopausal osteoporosis

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis

Pathophysiology of osteoporosis: new mechanistic insights

Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

Prevention and treatment of postmenopausal osteoporosis

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Use of bone turnover markers in postmenopausal osteoporosis

American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

MiR‐503 Regulates Osteoclastogenesis via Targeting RANK

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016

A broader strategy for osteoporosis interventions

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics

Hip fracture trends in the United States, 2002 to 2015

Circulating miR-181c-5p and miR-497-5p Are Potential Biomarkers for Prognosis and Diagnosis of Osteoporosis

Exploration of the miR‐187‐3p/CNR2 pathway in modulating osteoblast differentiation and treating postmenopausal osteoporosis through mechanical stress

Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways

Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil

MicroRNA‐218‐5p relieves postmenopausal osteoporosis through promoting the osteoblast differentiation of bone marrow mesenchymal stem cells

Suchergebnisse filtern